Exploring the potential mechanisms contributing to the interplay between COVID-19 and PCa suggests an apparent correlation between the targets of SARS-CoV-2 on host epithelial cells and the genetic anomalies and molecular markers of PCa, such as AR and TMPRSS2. This evidence concerns the gene AR and posterior cortical atrophy.